Logo image of TBPH

THERAVANCE BIOPHARMA INC (TBPH) Stock Earnings & Estimates

NASDAQ:TBPH - KYG8807B1068 - Common Stock

14.14 USD
+0.09 (+0.64%)
Last: 9/5/2025, 2:19:06 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TBPH revenue by date.TBPH revenue by date.
51.3M
-7.23%
57.424M
11.94%
64.381M
12.12%
114.83M
78.36%
105.43M
-8.19%
110.51M
4.82%
149.48M
35.26%
209.23M
39.97%
267.26M
27.74%
390.99M
46.30%
275.66M
-29.50%
EBITDA
YoY % growth
TBPH ebitda by date.TBPH ebitda by date.
-75.38M
67.48%
-47.139M
37.46%
-36.312M
22.97%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TBPH ebit by date.TBPH ebit by date.
-79.1M
66.72%
-53.292M
32.63%
-42.436M
20.37%
-14.688M
65.39%
-40.052M
-172.69%
-37.74M
5.77%
-8.26M
78.11%
44.619M
640.16%
100.02M
124.16%
239.04M
138.99%
136.17M
-43.03%
Operating Margin
TBPH operating margin by date.TBPH operating margin by date.
-154.19%-92.80%-65.91%-12.79%-37.99%-34.15%-5.53%21.33%37.42%61.14%49.40%
EPS
YoY % growth
TBPH eps by date.TBPH eps by date.
-0.67
77.29%
-0.97
-44.78%
-1.09
-12.37%
0.94
186.40%
-0.26
-127.29%
0.35
238.10%
0.67
88.71%
1.54
130.44%
2.28
47.80%
4.09
79.28%
0.95
-76.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26
EPS
Q2Q % growth
-0.14
47.43%
0.25
180.06%
-0.02
92.44%
-0.02
96.22%
Revenue
Q2Q % growth
19.658M
16.54%
52.76M
181.33%
21.879M
42.18%
22.593M
-13.75%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-8.429M
9.12%
11.152M
221.22%
-4.488M
68.91%
-4.488M
-64.70%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.54
-92.86%
0.69-1.23-178.66%
Q1 2025
Q2Q % growth
-0.27
-12.50%
-0.23-0.04-16.10%
Q4 2024
Q2Q % growth
-0.31
-82.35%
-0.21-0.10-44.72%
Q3 2024
Q2Q % growth
-0.26
-52.94%
-0.24-0.02-10.35%
Q2 2024
Q2Q % growth
-0.28 -0.21-0.07-32.93%
Q1 2024
Q2Q % growth
-0.24
31.43%
-0.260.027.36%
Q4 2023
Q2Q % growth
-0.17
-13.33%
-0.15-0.02-12.11%
Q3 2023
Q2Q % growth
-0.17
19.05%
-0.210.0420.51%
Q2 2023
Q2Q % growth
-0.28
-211.11%
-0.21-0.07-30.72%
Q1 2023
Q2Q % growth
-0.35
-59.09%
-0.25-0.10-39.30%
Q4 2022
Q2Q % growth
-0.15
65.12%
-0.180.0314.75%
Q3 2022
Q2Q % growth
-0.21
56.25%
-0.19-0.02-12.81%
Q2 2022
Q2Q % growth
-0.09
88.75%
0.11-0.20-180.95%
Q1 2022
Q2Q % growth
-0.22
82.26%
-0.11-0.11-103.48%
Q4 2021
Q2Q % growth
-0.43
53.26%
-0.34-0.09-27.17%
Q3 2021
Q2Q % growth
-0.48
58.62%
-0.570.0915.80%
Q2 2021
Q2Q % growth
-0.80
20.00%
-1.020.2221.48%
Q1 2021
Q2Q % growth
-1.24
11.43%
-1.07-0.17-15.99%
Q4 2020
Q2Q % growth
-0.92
21.37%
-1.040.1211.21%
Q3 2020
Q2Q % growth
-1.16
-10.48%
-1.03-0.13-12.28%
Q2 2020
Q2Q % growth
-1.00
-38.89%
-1.000.00-0.42%
Q1 2020
Q2Q % growth
-1.40
-6.06%
-1.10-0.30-27.68%
Q4 2019
Q2Q % growth
-1.17 -1.15-0.02-1.36%
Q3 2019
Q2Q % growth
-1.05 -1.130.086.98%
Q2 2019
Q2Q % growth
-0.72 -1.260.5442.88%
Q1 2019
Q2Q % growth
-1.32 -1.21-0.11-8.75%
TBPH Yearly EPS VS EstimatesTBPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
26.195M
83.75%
26.555M-360K-1.36%
Q1 2025
Q2Q % growth
15.388M
6.10%
15.81M-422K-2.67%
Q4 2024
Q2Q % growth
18.754M
6.77%
17.432M1.322M7.58%
Q3 2024
Q2Q % growth
16.868M
7.49%
15.65M1.218M7.78%
Q2 2024
Q2Q % growth
14.256M
3.69%
15.762M-1.506M-9.55%
Q1 2024
Q2Q % growth
14.503M
39.22%
14.242M261K1.83%
Q4 2023
Q2Q % growth
17.565M
20.31%
18.038M-473K-2.62%
Q3 2023
Q2Q % growth
15.693M
25.54%
15.302M391K2.56%
Q2 2023
Q2Q % growth
13.749M
23.86%
15.729M-1.98M-12.59%
Q1 2023
Q2Q % growth
10.417M
-21.08%
13.988M-3.571M-25.53%
Q4 2022
Q2Q % growth
14.6M
-2.01%
16.041M-1.441M-8.98%
Q3 2022
Q2Q % growth
12.5M
-5.30%
12.046M454K3.77%
Q2 2022
Q2Q % growth
11.1M
-13.95%
12.661M-1.561M-12.33%
Q1 2022
Q2Q % growth
13.2M
-7.69%
14.774M-1.574M-10.65%
Q4 2021
Q2Q % growth
14.9M
-20.32%
13.751M1.149M8.36%
Q3 2021
Q2Q % growth
13.2M
-27.87%
14.689M-1.489M-10.14%
Q2 2021
Q2Q % growth
12.9M
-14.00%
15.715M-2.815M-17.91%
Q1 2021
Q2Q % growth
14.3M
-28.14%
17.615M-3.315M-18.82%
Q4 2020
Q2Q % growth
18.7M
-36.61%
21.263M-2.563M-12.05%
Q3 2020
Q2Q % growth
18.3M
47.58%
18.945M-645K-3.40%
Q2 2020
Q2Q % growth
15M
-42.75%
20.033M-5.033M-25.12%
Q1 2020
Q2Q % growth
19.9M
275.47%
18.49M1.41M7.63%
Q4 2019
Q2Q % growth
29.5M 17.172M12.328M71.79%
Q3 2019
Q2Q % growth
12.4M 11.856M544K4.59%
Q2 2019
Q2Q % growth
26.2M 11.083M15.117M136.40%
Q1 2019
Q2Q % growth
5.3M 16.54M-11.24M-67.96%
TBPH Yearly Revenue VS EstimatesTBPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS19.57% 33% 141.08% 376.45%
Revenue1.07% -4.59% 17.54% 18.05%